Current treatments, including fundus laser photocoagulation, corticosteroid therapy, and anti-vascular endothelial growth factor (anti-VEGF) injections, aim to mitigate vision loss primarily due to macular edema and neovascularization. The gene discussed is VEGFA; the disease is macular retinal edema.